What's Next: Seres Therapeutics's Earnings Preview

Seres Therapeutics (NASDAQ:MCRB) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Seres Therapeutics will report an earnings per share (EPS) of $-0.24.

Seres Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the ...